Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)

2 total trials

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children aged ≥ 1 to < 7 Years with Neurofibromatosis Type 1 … Recruitment ended

2023-506357-38-00 9 2022-02-17
Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children with Neurofibro … Recruitment ended

2024-517216-29-00 3 2021-08-06

Showing 1–2 of 2 trials